Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib and radiotherapy in head and neck sarcomas
NCT03539172Phase 2Unknown
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in soft tissue sarcoma (STS), bone sarcoma, sponsored by Shanghai Ninth People's Hospital. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT03539172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03539172.